tinkie
08-09

$Novavax(NVAX)$ if things go really, really well... eventually I can see a scenario where nvax is worth $5-$15B. but a LOT has to happen for that to even be on the table. it's very difficult for companies in competitive categories to gain market share. the only way is with truly differentiable products with unique benefits and high value. it's very hard to have and keep that. novavax has a lot of work to do

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment